Albany Molecular Research, Inc. (AMRI) Announces First Quarter 2011 Results

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2011.

First Quarter 2011 Results

Total revenue for the first quarter of 2011 was $56.9 million, an increase of 15% compared to total revenue of $49.3 million reported in the first quarter of 2010.

Total contract revenue for the first quarter of 2011 was $42.9 million, an increase of 10% compared to total contract revenue of $38.9 million reported in the first quarter of 2010. Total contract revenue encompasses revenue from AMRI’s Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing business components.

MORE ON THIS TOPIC